Literature DB >> 6304685

Identification of the leukemogenic protein of avian myeloblastosis virus and of its normal cellular homologue.

W J Boyle, J S Lipsick, E P Reddy, M A Baluda.   

Abstract

The genome of the replication-defective avian myeloblastosis virus (AMV) contains an inserted cellular sequence (amv) that is part of the oncogene responsible for acute myeloblastic leukemia in chickens infected with AMV. Three antisera raised against distinct synthetic peptides predicted from the long open reading frame of amv specifically precipitated the same 48-kilodalton protein (p48amv) from leukemic myeloblasts but not from normal hematopoietic tissue, fibroblasts, or from fibroblasts infected with the AMV helper virus, MAV-1 (myeloblastosis-associated virus type 1). p48amv is not glycosylated or phosphorylated and does not appear to act as a protein kinase in vitro. The same three antisera that recognized p48amv also specifically precipitated a common 110-kilodalton protein from normal uninfected hematopoietic tissue. This normal cellular homologue of the AMV leukemogenic protein, p110proto-amv, was not present in normal fibroblasts, MAV-1 infected fibroblasts, or, interestingly, in some leukemic myeloblasts. We conclude that p48amv is the leukemogenic product of an altered, transduced, partial protooncogene. Short helper-virus sequences provide its carboxyl terminus and also may provide the amino terminus.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6304685      PMCID: PMC393926          DOI: 10.1073/pnas.80.10.2834

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  The isolation and properties of granulocytic colony-stimulating activities from medium conditioned by human peripheral leucocytes.

Authors:  G B Price; J S Senn; E A McCulloch; J E Till
Journal:  Biochem J       Date:  1975-05       Impact factor: 3.857

2.  Transcripts from the cellular homologs of retroviral oncogenes: distribution among chicken tissues.

Authors:  T J Gonda; D K Sheiness; J M Bishop
Journal:  Mol Cell Biol       Date:  1982-06       Impact factor: 4.272

3.  Identification of a transformation-specific antigen induced by an avian sarcoma virus.

Authors:  J S Brugge; R L Erikson
Journal:  Nature       Date:  1977-09-22       Impact factor: 49.962

4.  Protein kinase activity associated with the avian sarcoma virus src gene product.

Authors:  M S Collett; R L Erikson
Journal:  Proc Natl Acad Sci U S A       Date:  1978-04       Impact factor: 11.205

5.  Virus particles associated with "nonproducer" Rous sarcoma cells.

Authors:  R M Dougherty; H S Di Stefano
Journal:  Virology       Date:  1965-11       Impact factor: 3.616

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Fluorographic detection of radioactivity in polyacrylamide gels with the water-soluble fluor, sodium salicylate.

Authors:  J P Chamberlain
Journal:  Anal Biochem       Date:  1979-09-15       Impact factor: 3.365

8.  Location of envelope-specific and sarcoma-specific oligonucleotides on RNA of Schmidt-Ruppin Rous sarcoma virus.

Authors:  L H Wang; P H Duesberg; S Kawai; H Hanafusa
Journal:  Proc Natl Acad Sci U S A       Date:  1976-02       Impact factor: 11.205

9.  Distribution of deoxyribonucleic acid complementary to the ribonucleic acid of avian myeloblastosis virus in tissues of normal and tumor-bearing chickens.

Authors:  M A Baluda; W N Drohan
Journal:  J Virol       Date:  1972-11       Impact factor: 5.103

10.  Avian myeloblastosis virus proteins in leukemic chicken myeloblasts.

Authors:  R F Silva; M A Baluda
Journal:  J Virol       Date:  1980-09       Impact factor: 5.103

View more
  35 in total

1.  Characterization of the v-myb DNA binding domain.

Authors:  T Oehler; H Arnold; H Biedenkapp; K H Klempnauer
Journal:  Nucleic Acids Res       Date:  1990-04-11       Impact factor: 16.971

2.  Two nuclear oncogenic proteins, P135gag-myb-ets and p61/63myc, cooperate to induce transformation of chicken neuroretina cells.

Authors:  P Amouyel; V Laudet; P Martin; R P Li; B Quatannens; D Stéhelin; S Saule
Journal:  J Virol       Date:  1989-08       Impact factor: 5.103

3.  Definition of functional domains in P135gag-myb-ets and p48v-myb proteins required to maintain the response of neuroretina cells to basic fibroblast growth factor.

Authors:  C Garrido; D Leprince; J S Lipsick; D Stehelin; D Gospodarowicz; S Saule
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

4.  Transformation by v-myb correlates with trans-activation of gene expression.

Authors:  T Lane; C Ibanez; A Garcia; T Graf; J Lipsick
Journal:  Mol Cell Biol       Date:  1990-06       Impact factor: 4.272

5.  The ets sequence is required for induction of erythroblastosis in chickens by avian retrovirus E26.

Authors:  M F Nunn; T Hunter
Journal:  J Virol       Date:  1989-01       Impact factor: 5.103

6.  v-myb does not prevent the expression of c-myb in avian erythroblasts.

Authors:  J S Lipsick
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

7.  DNA-binding activity associated with the v-myb oncogene product is not sufficient for transformation.

Authors:  C E Ibanez; A Garcia; U Stober-Grässer; J S Lipsick
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

8.  Structural organization and expression of human DNA sequences related to the transforming gene of avian myeloblastosis virus.

Authors:  G Franchini; F Wong-Staal; M A Baluda; C Lengel; S R Tronick
Journal:  Proc Natl Acad Sci U S A       Date:  1983-12       Impact factor: 11.205

9.  Isolation of monoclonal antibodies specific for products of avian oncogene myb.

Authors:  G I Evan; G K Lewis; J M Bishop
Journal:  Mol Cell Biol       Date:  1984-12       Impact factor: 4.272

10.  Avian myeloblastosis virus and E26 virus oncogene products are nuclear proteins.

Authors:  W J Boyle; M A Lampert; J S Lipsick; M A Baluda
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.